文献速递中药与中成药合理使用中医内科

疾病状态依赖性药物-草药相互作用:NASH降低辛伐他汀与栀子合用大鼠的肝毒性风险

Disease Status-Dependent Drug-Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis.
PubMed 文献 · Front Pharmacol · 2021-04-23

本研究在健康与NASH大鼠中评估辛伐他汀(SV)与栀子(GJ)合用的相互作用及肝毒性。结果显示,GJ在健康大鼠中上调肝脏P-gp而降低SV及其活性代谢物SVA的系统暴露,但在NASH大鼠中无此效应;SV在两种状态下均增加栀子苷暴露。健康大鼠合用出现肝损伤,而NASH大鼠合用反而降低ALT、AST及血脂水平。

要点

  • GJ仅在健康大鼠中通过上调P-gp降低SV/SVA暴露,NASH状态下该效应消失。
  • 健康大鼠合用SV与GJ出现肝损伤,与栀子苷-蛋白加合物及炎症相关。
  • NASH大鼠中合用SV与GJ降低ALT、AST及血脂,提示疾病状态改变肝毒性风险。

核心结论

  • SV与GJ合用可在健康大鼠中引起短期和长期肝损伤,但NASH状态可降低该风险。
  • GJ对SV/SVA暴露的影响在健康与NASH大鼠中不同,呈疾病状态依赖性。

研究设计与样本

  • 健康与NASH大鼠分别接受两周SV(p.o.,8.66 mg/kg,每日一次)和/或GJ(p.o.,325 mg/kg,每日两次)。
  • 比较SV、SVA及栀子苷的药代动力学、肝脏Cyp2c11/Oatp1b2/P-gp表达及肝损伤生物标志物。
  • 停药90天后评估肝脏组织学以观察长期影响。

主要发现

  • GJ在健康大鼠中上调肝脏P-gp表达,降低SV和SVA的系统暴露,但在NASH大鼠中无此效应。
  • SV在健康与NASH大鼠中均通过抑制P-gp活性增加栀子苷的系统暴露。
  • 健康大鼠合用SV与GJ升高血清ALT和AST,可能与栀子苷-蛋白加合物形成、炎症浸润及iNOS/COX-1表达加重有关。
  • NASH大鼠中SV和/或GJ降低血清ALT、AST、LDL/vLDL及TC水平,并减轻肝脏炎症浸润和iNOS/COX-1表达。
  • 停药90天后,健康大鼠合用组肝纤维化较NASH大鼠更严重。

关键数值与推荐

  • SV剂量8.66 mg/kg每日一次,GJ剂量325 mg/kg每日两次,均给药两周。
  • 健康大鼠合用SV与GJ后血清ALT和AST升高。
  • NASH大鼠中SV和/或GJ降低血清ALT、AST、LDL/vLDL及TC水平。

临床怎么用

  • 临床对健康或非NASH患者合用辛伐他汀与栀子时需警惕肝损伤风险。
  • NASH患者合用辛伐他汀与栀子时肝毒性风险可能降低,但仍需监测肝功能。
  • 药物-草药相互作用评估应考虑疾病状态对P-gp等转运体表达的影响。

局限性

  • 研究仅在大鼠中进行,结论外推至人体需谨慎。
  • 样本量、P值等统计细节未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Concurrent use of simvastatin (SV) and Gardenia jasminoides J. Ellis (GJ) was adopted in patients with multi-morbidity, such as stroke rehabilitation patients with NASH. Although hepatotoxicity has been reported in both of them and NASH could alter the pharmacokinetics of drugs/herbs, the interaction between SV and GJ and the related hepatotoxicity remained uninvestigated under neither healthy nor NASH condition. The current study aimed to evaluate the potential hepatotoxicity resulted from the interactions between SV and GJ in both healthy and NASH rats. Both healthy and NASH rats received two-week SV (p. o., 8.66 mg/kg, once daily) and/or GJ (p.o., 325 mg/kg, twice daily). Pharmacokinetic profiles of SV, simvastatin acid (SVA, active metabolite of SV), and geniposide (major component in GJ); hepatic Cyp2c11/Oatp1b2/P-gp expression; and biomarker levels of liver function, lipid levels, and liver histology were compared to demonstrate the interactions in rats. To explore the mechanism of the interaction-mediated hepatotoxicity, hepatic genipin-protein adduct content and iNOS/COX-1/COX-2 expressions from related groups were compared. Moreover, liver histology of healthy/NASH rats at 90 days after discontinuation of two-week GJ in the absence and presence of SV was evaluated to estimate the long-term impact of the interactions. GJ reduced the systemic exposures of SV and SVA by up-regulating the hepatic P-gp expression in healthy but not NASH rats. Meanwhile, SV increased the systemic exposure of geniposide via inhibiting the activity of P-gp in both healthy and NASH rats. Although neither SV nor GJ induced hepatotoxicity in healthy rats, their co-treatment elevated serum ALT and AST levels, which may attribute to the aggravated genipin-protein adduct formation, inflammation infiltration, and iNOS/COX-1 expressions in the liver. In NASH rats, SV and/or GJ reduced serum ALT, AST, LDL/vLDL, and TC levels via alleviating hepatic inflammation infiltration and iNOS/COX-1 expressions. Moreover, in comparison to NASH rats, more severe fibrosis was observed in the livers of healthy rats at 90 days after discontinuation of two-week SV and GJ coadministration. Although interactions between SV and GJ induced short-term and long-term liver injuries in healthy rats, NASH condition in rats could lower such risk.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li Z, Lyu Y, Zhao J, et al. Disease Status-Dependent Drug-Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis. Front Pharmacol. 2021. PMID: 33967756. doi:10.3389/fphar.2021.622040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。